Cargando…
FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
Rho-Rho kinase (Rho-ROCK) triggers an intracellular signalling cascade that regulates cell survival, death, adhesion, migration, neurite outgrowth and retraction and influences the generation and development of several neurological disorders. Although Fasudil, a ROCK inhibitor, effectively suppresse...
Autores principales: | Xin, Yan-Le, Yu, Jie-Zhong, Yang, Xin-Wang, Liu, Chun-Yun, Li, Yan-Hua, Feng, Ling, Chai, Zhi, Yang, Wan-Fang, Wang, Qing, Jiang, Wei-Jia, Zhang, Guang-Xian, Xiao, Bao-Guo, Ma, Cun-Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721545/ https://www.ncbi.nlm.nih.gov/pubmed/26223433 http://dx.doi.org/10.1042/BSR20150032 |
Ejemplares similares
-
Expression of Concern: FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
Publicado: (2022) -
FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms
por: Li, Yan-Hua, et al.
Publicado: (2017) -
Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis
por: Guo, Shang‐De, et al.
Publicado: (2019) -
Therapeutic effect of Rho kinase inhibitor FSD-C10 in a mouse model of Alzheimer's disease
por: Gu, Qing-Fang, et al.
Publicado: (2018) -
FSD operating experiences at Berkeley
por: Hall, D
Publicado: (1963)